Novartis logo


Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Flexible Media Releases

Novartis in Society US Report 2020


Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

Novartis US Foundation
Initiatives summarizing efforts from the Novartis US Foundation.

Novartis COVID-19 Trials
Novartis clinical trial efforts in COVID-19 R&D.

Novartis US Foundation COVID-19 Response
In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...

Novartis – science based innovation for better patient outcomes
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novartis Foundation Leprosy Elimination Initiative
The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

Novartis Access: Medicines to treat chronic diseases in lower-income countries
Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

The Novartis Malaria Initiative
For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...